Anthranoid laxative abuse--a risk for colorectal cancer?

C P Siegers, E von Hertzberg-Lottin, M Otte, B Schneider

Institute of Toxicology, Medical University of Lubeck, Germany.

Anthranoid-containing laxatives--aloe, cascara, frangula, and rheum--may play a role in colorectal cancer. This risk is particularly important in view of the wide abuse of self administered laxatives for chronic constipation. There are data on the genotoxic potential of anthranoids and there is evidence of a tumourigenic potential in rodents. A case report and clinical-epidemiological studies have evaluated the cancer risk in patients who have abused anthranoid laxatives over a long period. Pseudomelanosis coli is a reliable parameter of chronic laxative abuse (> 9-12 months) and is specific for anthranoid drugs. In a retrospective study of 3049 patients who underwent diagnostic colorectal endoscopy the incidence of pseudomelanosis coli was 3.13% in patients without pathological changes. In those with colorectal adenomas, the incidence increased to 8.64% (p < 0.01), and in those with colorectal carcinomas it was 3.29%. This lower rate was probably caused by incomplete documentation of pseudomelanosis coli in those with carcinoma. In a prospective study of 1095 patients, the incidence of pseudomelanosis coli was 6.9% for patients with no abnormality seen on endoscopy, 9.8% (p = 0.068) for patients with adenomas, and 18.6% for patients with colorectal carcinomas. From these data a relative risk of 3.04 (1.18, 4.90; 95% confidence interval) can be calculated for colorectal cancer as a result of anthranoid laxative abuse.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Nascimbeni, R., Donato, F., Ghirardi, M., Mariani, P., Villanacci, V., Salerni, B. (2002). Constipation, Anthranoid Laxatives, Melanosis Coli, and Colon Cancer: A Risk Assessment Using Aberrant Crypt Foci. Cancer Epidemiol. Biomarkers Prev. 11: 753-757 [Abstract] [Full Text]  
• Nusko, G, Schneider, B, Schneider, I, Wittekind, C., Hahn, E G (2000). Anthranoid laxative use is not a risk factor for colorectal neoplasia: results of a prospective case control study. Gut 46: 651-655 [Abstract] [Full Text]  
• Pommer, W., Bronder, E., Klimpel, A., Helmert, U., Greiser, E., Molzahn, M. (1999). Urothelial cancer at different tumour sites: role of smoking and habitual intake of analgesics and laxatives. Results of the Berlin Urothelial Cancer Study. Nephrol Dial Transplant 14: 2892-2897 [Abstract] [Full Text]  
• Pohl, H. R., Roney, N., Fay, M., Chou, C.-H. S.J., Wilbur, S., Holler, J. (1999). Site-specific consultation for a chemical mixture. Toxicol Ind Health 15: 470-479 [Abstract]  
• Mueller, S. O., Stopper, H., Dekant, W. (1998). Biotransformation of the Anthraquinones Emodin and Chrysophanol by Cytochrome P450 Enzymes. Bioactivation to Genotoxic Metabolites. Drug Metab. Dispos. 26: 540-546 [Abstract] [Full Text]